Psychological impact of Crohn's disease on patients in remission: Anxiety and depression risks;Impacto psicológico de la enfermedad de Crohn en pacientes en remisión: Riesgo de ansiedad y depresión

Revista Espanola de Enfermedades Digestivas

Volumn 101, Issue 4, 2009, Pages 249-257

  Iglesias, M ^a   Barreiro De Acosta, Manuel ^a   Vazquez I ^b   Figueiras, A ^a   Nieto, L ^a   Lorenzo, A ^a   Dominguez Munoz J E ^a  

^a Instituto de Salud Carlos III   (Spain)

^b UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Anxiety; Crohn's disease; Depression; Remission

Indexed keywords

ADALIMUMAB; C REACTIVE PROTEIN; INFLIXIMAB;

ADULT; AGED; ANXIETY DISORDER; ARTICLE; CLINICAL EVALUATION; CROHN DISEASE; CROHN DISEASE ACTIVITY INDEX; DEMOGRAPHY; DEPRESSION; DISEASE ASSOCIATION; DISEASE DURATION; FEMALE; HOSPITAL ANXIETY AND DEPRESSION SCALE; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN BLOOD LEVEL; PSYCHOLOGICAL ASPECT; QUESTIONNAIRE; REMISSION; SCORING SYSTEM;

ADOLESCENT; ADULT; AGED; ANXIETY; CROHN DISEASE; DEPRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; REMISSION INDUCTION; YOUNG ADULT;

EID: 70349950477     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (41)

1. Maunder RG, Levenstein S. The role of stress in the development and clinical course of inflammatory bowel disease: epidemiological evidence. Curr Mol Med 2008; 8: 247-252 (Pubitemid 351982528)
2. Maunder RG. Evidence that stress contributes to inflammatory bowel disease: evaluation, synthesis, and future directions. Inflamm Bowel Dis 2005; 11: 600-608
3. Helzer JE, Stillings WA, Chammas S, Norland CC, Alpers DH. A controlled study of the association between ulcerative colitis and psychiatric diagnoses. Dig Dis Sci 1982; 27: 513-518
4. Addolorato G, Capristo E, Stefanini GF, Gasbarrini G. Inflammatory bowel disease: a study of the association between anxiety and depression, physical morbidity, and nutritional status. Scand J Gastroenterol 1997; 32: 1013-1021 (Pubitemid 27433665)
5. O'Malley PG, Jackson JL, Kroenke K, Yoon K, Hornstein E, Dennis GJ. The value of screening for psychiatric disorders in rheumatology referrals. Arch Intern Med 1998; 158: 2357-2362 (Pubitemid 28536489)
6. Maiden NL, Hurst NP, Lochhead A, Carson AJ, Sharpe M. Medically unexplained symptoms in patients referred to a specialist rheumatology service: prevalence and associations. Rheumatology 2003; 42: 108-112 (Pubitemid 36131576)
7. Walker EA, Unutzer J, Rutter C, Gelfand A, Saunders K, VonKorff M, et al. Costs of health care use by women HMO members with a history of childhood abuse and neglect. Arch Gen Psychiatry 1999; 56: 609-613 (Pubitemid 29315632)
8. Porcelli P, Leoci C, Guerra V. A prospective study of the relationship between disease activity and psychologic distress in patients with inflammatory bowel disease. Scand J Gastroenterol 1996; 31:792-796 (Pubitemid 26255048)
9. Mittermaier C, Dejaco C, Waldhoer T, Oefferlbauer-Ernst A, Miehsler W, Beier M, et al. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004; 66: 79-84. (Pubitemid 38146536)
10. Casellas F, López Vivancos J, Malagelada JR. Previous experience and quality of life in patients with inflammatory bowel disease during relapse. Rev Esp Enferm Dig 2003; 95: 476-479 (Pubitemid 37062690)
11. Drossman DA, Li Z, Leserman J, Patrick DL. Ulcerative colitis and Crohn's disease health status scales for research and clinical practice. J Clin Gastroenterol 1992; 15: 104-112
12. Bernklev T, Jahnsen J, Aadland E, Sauar J, Schulz T, Lygren I, et al. Health-related quality of life in patients with inflammatory bowel disease five years after the initial diagnosis. Scand J Gastroenterol 2004; 39: 365-373 (Pubitemid 38526725)
13. Casellas F, Arenas JI, Baudet JS, Fábregas S, García N, Gelabert J, et al. Impairment of health-related quality of life in patients with inflammatory bowel disease: a Spanish multicenter study. Inflamm Bowel Dis 2005; 11: 488-496 (Pubitemid 40704084)
14. Lespérance F, Frasure-Smith N, Talajic M, Bourassa MG. Five-year risk of cardiac mortality in relation to initial severity and one-year changes in depression symptoms after myocardial infarction. Circulation. 2002; 105: 1049-1053 (Pubitemid 34212612)
15. Watson M, Haviland JS, Greer S, Davidson J, Bliss JM. Influence of psychological response on survival in breast cancer: a population-based cohort study. Lancet 1999; 354: 1331-1336 (Pubitemid 29481628)
16. Lustman PJ, Griffith LS, Freedland KE, Clouse RE. The course of major depression in diabetes. Gen Hosp Psychiatry 1997; 19: 138-143
17. Vermeire S, van Assche G, Rutgeerts P. Review article: altering the natural history of Crohn's disease - evidence for and against current therapies. Aliment Pharmacol Ther 2007; 25: 3-12. (Pubitemid 44902859)
18. Travis S. Advances in therapeutic approaches to ulcerative colitis and Crohn's disease. Curr Gastroenterol Rep 2005; 7: 475-484 (Pubitemid 43009339)
19. Stange EF, Travis SP, Vermeire S, Beglinger C, Kupcinkas L, Geboes K, et al. European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 2006; 55 Supl. 1: i1-15. (Pubitemid 43268290)
20. Rutgeerts P, Vermeire S, Van Assche G. Mucosal healing in inflammatory bowel disease: impossible ideal or therapeutic target? Gut 2007; 56: 453-455
21. Lennard-Jones JE. Classification of inflammatory bowel disease. Scand J Gastroenterol Suppl 1989; 170: 2-6.
22. Casellas F, López-Vivancos J, Casado A, Malagelada JR. Factors affecting health related quality of life of patients with inflammatory bowel disease. Qual Life Res 2002; 11: 775-781 (Pubitemid 35388174)
23. López Blanco B, Moreno-Jiménez B, Devesa Múgica JM, Rodríguez Muñoz A. Relationship between socio-demographic and clinical variables, and health-related quality of life in patients with inflammatory bowel disease. Rev Esp Enferm Dig 2005; 97: 887-898 (Pubitemid 44483734)
24. Silverberg MS, Satsangi J, Ahmad T, Arnott ID, Bernstein CN, Brant SR, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: Report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19 (Supl. A): 5-36.
25. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370
26. a ed. Editorial Masson. p. 47-54.
27. Tully PJ, Baker RA, Turnbull D, Winefield H. The role of depression and anxiety symptoms in hospital readmissions after cardiac surgery. J Behav Med 2008; 31: 281-290
28. Carone AR, D'Amore S, Albanese L, Craig F, Scagliusi P, D'Amore M. Hospital anxiety and depression. Reumatismo 2007; 59: 304-315
29. Häuser W, Janke KH, Stallmach A. Mental disorder and psychologic distress in patients with ulcerative colitis after ileal pouch-anal anastomosis. Dis Colon Rectum 2005; 48: 952-962 (Pubitemid 40884184)
30. Yen JY, Chen YH, Long CY, Chang Y, Yen CF, Chen CC, et al. Risk factors for major depressive disorder and the psychological impact of hysterectomy: a prospective investigation. Psychosomatics 2008; 49: 137-142
31. Siegel AM, Cascino GD, Fessler AJ, So EL, Meyer FB. Psychiatric co-morbidity in 75 patients undergoing epilepsy surgery: lack of correlation with pathological findings. Epilepsy Res 2008; 80: 158-162
32. Lichtenstein GR, Feagan BG, Cohen RD, Salzberg BA, Diamond RH, Chen DM, et al. Serious infections and mortality in association with therapies for Crohn's disease: TREAT registry. Clin Gastroenterol Hepatol 2006; 4: 621-630
33. Brown ES, Suppes T. Mood symptoms during corticosteroid therapy: a review. Harv Rev Psychiatry 1998; 5: 239-246 (Pubitemid 28092100)
34. Stuart FA, Segal TY, Keady S. Adverse psychological effects of corticosteroids in children and adolescents. Arch Dis Child 2005; 90: 500-506 (Pubitemid 40627447)
35. Persoons P, Vermeire S, Demyttenaere K, Fischler B, Vandenberghe J, Van Oudenhove L, et al. The impact of major depressive disorder on the short- and long-term outcome of Crohn's disease treatment with infliximab. Aliment Pharmacol Ther 2005; 22: 101-110 (Pubitemid 41039698)
36. Andrews H, Barczak P, Allan RN. Psychiatric illness in patients with inflammatory bowel disease. Gut 1987; 28: 1600-1604 (Pubitemid 18033067)
37. North CS, Alpers DH, Helzer JE, Spitznagel EL, Clouse RE. Do life events or depression exacerbate inflammatory bowel disease? A prospective study. Ann Intern Med. 1991; 114: 381-386
38. Levenstein S, Prantera C, Varvo V, Scribano ML, Andreoli A, Luzi C, et al. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000; 95: 1213-1220 (Pubitemid 30263515)
39. Díaz Sibaja MA, Comeche Moreno MI, Mas Hesse B. Protocolized cognitive-behavioural group therapy for inflammatory bowel disease Rev Esp Enferm Dig 2007; 99: 593-598
40. Mussell M, Böcker U, Nagel N, Olbrich R, Singer MV. Reducing psychological distress in patients with inflammatory bowel disease by cognitive-behavioural treatment: exploratory study of effectiveness. Scand J Gastroenterol 2003; 38: 755-762 (Pubitemid 36920498)
41. García Vega E, Fernández Rodríguez C, Sánchez Lombraña JL. Behavioral profile of the patient with Crohn's disease. Rev Esp Enferm Dig 1994; 86: 791-795